Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin
about
Phytochemicals Approach for Developing Cancer Immunotherapeutics.STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer.Silibinin: an old drug for hematological disorders.Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways.Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway.
P2860
Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Response of brain metastasis f ...... l product containing silibinin
@en
Response of brain metastasis f ...... product containing silibinin.
@nl
type
label
Response of brain metastasis f ...... l product containing silibinin
@en
Response of brain metastasis f ...... product containing silibinin.
@nl
prefLabel
Response of brain metastasis f ...... l product containing silibinin
@en
Response of brain metastasis f ...... product containing silibinin.
@nl
P2093
P2860
P50
P356
P1433
P1476
Response of brain metastasis f ...... l product containing silibinin
@en
P2093
Jordi Marruecos
Manel Haro
Noemí Cañete
P2860
P304
32006-32014
P356
10.18632/ONCOTARGET.7900
P407
P577
2016-03-03T00:00:00Z